Xencor, Inc.
€10.3
EUR
Last updated on --.
24h volume49.80K
24h highest10.3767 EUR
24h lowest9.9043 EUR
24h Price movement+3.20%
XNCR recent prices
24 Hours
+3.20%+€0.31955
30 days
-11.18%-€1.259
60 days
-1.14%-€0.11167
90 days
-14.13%-€1.645
Key data
Previous close9.9902 EUR
Market cap720.94M EUR
Volume49.80K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.0015 EUR
Net income (FY)-148.11M EUR
Revenue (FY)83.63M EUR
Last report dateMay 6, 2026
About Xencor, Inc.
HeadquartersPASADENA
Employees (FY)260.00
Revenue per employee (FY)321.66K EUR
Net income per employee (FY)-569.65K EUR
Listed onNasdaq
XNCR conversion tables
 |  |
|---|---|
| 0.5 XNCR | 5.154 EUR |
| 1 XNCR | 10.3 EUR |
| 5 XNCR | 51.54 EUR |
| 10 XNCR | 103.09 EUR |
| |
|---|---|
| 0.5 EUR | 0.048498 XNCR |
| 1 EUR | 0.096996 XNCR |
| 5 EUR | 0.48498 XNCR |
| 10 EUR | 0.96996 XNCR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
XNCR is trading at €10.30, +3.20% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XNCR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XNCR is currently trading at €10.30, +3.20% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XNCR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XNCR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XNCR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XNCR's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Xencor, Inc.'s market cap is currently 720.94M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume49.80K
24h highest10.3767 EUR
24h lowest9.9043 EUR
24h Price movement+3.20%
Start trade with XNCR Perpetual
Sign up to trade